Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1987
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EPA OPP 81-1 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Reference substance name:
Sodium Perborate Monohydrate (Grade A)
IUPAC Name:
Sodium Perborate Monohydrate (Grade A)
Details on test material:
-Name of test material (as cited in study report): Sodium Perborate Monohydrate (Grade A)
-Physical state: White granules
-Lot/batch No.: No data
-Stability under test conditions: Sponsor assumed responsibility for purity and stability determinations
-Storage condition of test material: at room temperature

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
-Source: Charles River Lab., Inc., Portage, MI
-Age at study initiation: young adult
-Weight at study initiation: 201-299 g
-Fasting period before study: overnight prior to dosing
-Housing: by sex in groups of 5
-Diet: ad lib.
-Water: ad lib.
-Acclimation period: 7 days

ENVIRONMENTAL CONDITIONS
-Temperature (°C): 21-25
-Humidity (%): 21-53

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
-Concentration in vehicle: 5, 10 and 20 % per mL
-Amount of vehicle: 10 mL/kg bw
-Justification for choice of vehicle: preparation of a uniform suspension

MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw

Rationale for the selection of the starting dose:
A dose range finding was performed using one male and one female rat per dose (500, 1000, 2000 or 5000 mg/kg bw). Based on this results, an initial level of 1000 mg/kg bw and two additional dose levels of 500 and 2000 mg/kg bw were used.
Doses:
500, 1000 and 2000 mg/kg bw
No. of animals per sex per dose:
5 m / 5 f
Control animals:
no
Details on study design:
-Duration of observation period following administration: 14 days
-Frequency of observations and weighing: Definite study animals were observed for clinical signs and mortality at 1, 2.5, and 4 hours post-dosing. Thereafter all animals were observed for clinical signs daily and twice daily for mortalities.
-Necropsy of survivors and animals found dead performed: yes (gross)
Statistics:
Average body weights. The oral LD50 was calculated for each sex and for both sexes combined.
Method according to Thakur & Fezio (1981) Drug Chem Toxicol 4 (3), 297 - 305

Results and discussion

Effect levelsopen allclose all
Sex:
male
Dose descriptor:
LD50
Effect level:
1 300 mg/kg bw
95% CL:
>= 850 - <= 1 990
Sex:
female
Dose descriptor:
LD50
Effect level:
890 mg/kg bw
95% CL:
>= 530 - <= 1 510
Sex:
male/female
Dose descriptor:
LD50
Effect level:
1 120 mg/kg bw
95% CL:
>= 770 - <= 1 630
Mortality:
500 mg: 0/10
1000 mg: 1/5 m and 3/5 f died within 48 hrs after dosing
2000 mg: 5/5 m and 5/5 f died within 24 hrs after dosing
Clinical signs:
other: >= 500 mg: diarrhoea >= 1000 mg: hypoactivity, ataxia
Gross pathology:
500 mg: alopecia of entire inguinal region in 1 f (most likely coincidental)
1000 mg: enlarged renal pelvis in 1 f (most likely coincidental)
2000 mg: frequent findings located in the gastrointestinal tract (distended stomach with thickened walls, staining of glandular mucosa, entire GI tract filled with clear fluid) both in m and f

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Remarks:
Migrated information
Conclusions:
The acute oral toxicity for Sodium Perborate Monohydrate was calculated to be 890 mg/kg for females, 1300 mg/kg for males and 1120 mg/kg for combined sexes.
According to OECD GHS, toxicity category IV (< 300 ≤ 2000) should be assigned.
Executive summary:

With Sodium Perborate Monohydrate an acute oral toxicity study was performed according to US-EPA Guideline OPP 81 -1. Five Sprague-Dawley rats per sex and group were dosed once via gavage with 500, 1000 and 2000 mg/kg bw. Animals were frequently monitored for clinical signs, body weight and mortality. All animals were examined for signs of macroscopic changes.

The acute oral LD50 was calculated to be 890 mg/kg for females, 1300 mg/kg for males and 1120 mg/kg for combined sexes. According to OECD GHS, toxicity category IV (< 300 ≤ 2000) should be assigned.